<DOC>
	<DOCNO>NCT02460471</DOCNO>
	<brief_summary>Phase II prospective study Palliative Radiotherapy 25 Gy 5 fraction , Intensity Modulated , frail patient incurable head neck cancer . Comprehensive Quality life ( QLQ-C30 , head neck module , QLQ C15 PAL ) toxicity data ( CTCAE v 4.0 ) collect .</brief_summary>
	<brief_title>Palliative Radiotherapy Protocol Head Neck Cancer</brief_title>
	<detailed_description>Patients deem frail radical treatment incurable tumour extension , determine experienced tumour board , eligible study palliative radiotherapy deliver intensity modulation , 25 Gy 5 daily fraction one week . This study conduct two academic center .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Able give inform consent Able complete QOL questionnaire Deemed incurable experience tumour board unwilling receive radical course radiation therapy Presence measurable disease Biopsy proven squamous salivary cancer head neck region Expected survival least 2 month . Pregnancy No previous RT neck plan receive concomitant chemotherapy Special histology ( Lymphoma , small cell cancer , metastasis site head neck region ) Unavailable followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Palliative Care</keyword>
	<keyword>IMRT</keyword>
</DOC>